SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 59 filers reported holding SAVARA INC in Q3 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $82,563 | -37.9% | 21,842 | -47.5% | 0.00% | – |
Q2 2023 | $132,960 | -50.6% | 41,615 | -69.8% | 0.00% | -100.0% |
Q1 2023 | $268,934 | +16.5% | 137,915 | -7.4% | 0.00% | 0.0% |
Q4 2022 | $230,818 | -7.3% | 148,915 | -7.2% | 0.00% | 0.0% |
Q3 2022 | $249,000 | +0.4% | 160,415 | -1.7% | 0.00% | 0.0% |
Q2 2022 | $248,000 | -36.2% | 163,115 | -45.0% | 0.00% | 0.0% |
Q1 2022 | $389,000 | -58.9% | 296,715 | -61.1% | 0.00% | -50.0% |
Q4 2021 | $946,000 | -9.5% | 763,115 | +0.8% | 0.00% | -33.3% |
Q3 2021 | $1,045,000 | -12.0% | 757,015 | +8.4% | 0.00% | 0.0% |
Q2 2021 | $1,187,000 | +290.5% | 698,115 | +377.5% | 0.00% | +200.0% |
Q1 2021 | $304,000 | +176.4% | 146,215 | +52.7% | 0.00% | – |
Q4 2020 | $110,000 | +3.8% | 95,773 | -1.7% | 0.00% | – |
Q3 2020 | $106,000 | -22.6% | 97,473 | +77.2% | 0.00% | – |
Q2 2020 | $137,000 | +389.3% | 55,015 | +309.7% | 0.00% | – |
Q1 2020 | $28,000 | -86.5% | 13,429 | -71.0% | 0.00% | – |
Q4 2019 | $208,000 | +87.4% | 46,329 | +10.9% | 0.00% | – |
Q3 2019 | $111,000 | – | 41,766 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,128,593 | $5,898,000 | 0.37% |
FARALLON CAPITAL MANAGEMENT LLC | 4,452,086 | $5,120,000 | 0.03% |
Woodline Partners LP | 374,904 | $431,000 | 0.01% |
Gyon Technologies Capital Management, LP | 19,679 | $23,000 | 0.01% |
AXA S.A. | 1,895,554 | $2,180,000 | 0.01% |
WEXFORD CAPITAL LP | 31,253 | $36,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 192,100 | $221,000 | 0.01% |
Capital Advantage, Inc. | 14,658 | $18,000 | 0.01% |
RGT Wealth Advisors, LLC | 10,000 | $12,000 | 0.00% |
Crewe Advisors LLC | 3,910 | $4,000 | 0.00% |